Trial intelligence / Profile preview

Chlorhexidine vs Povidone-iodine for Vaginal Surgery Prep

NCT03014778Phase 4Unknown

Sponsor
Emek Medical Center
Start
Jan 2017
Primary completion
Dec 2018
Countries
1
01

Overview

Phase 4, randomised, open-label trial of chlorhexidine in surgical site infection (SSI) (2 arms), sponsored by Emek Medical Center. Primary endpoint: Change in the number of colonies. Status: unknown.

02

Drugs

chlorhexidine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT03014778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03014778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call